A. D. DAVID MACKAY - 31 Dec 2024 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Issuer symbol
CLX
Transactions as of
31 Dec 2024
Net transactions value
$0
Form type
4
Filing time
03 Jan 2025, 16:35:25 UTC
Previous filing
08 May 2024
Next filing
16 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +61 +0.78% $0.000000 7,904 09 Feb 2024 Common Stock 61 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +66 +0.84% $0.000000 7,970 10 May 2024 Common Stock 66 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +61 +0.77% $0.000000 8,031 30 Aug 2024 Common Stock 61 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +60 +0.75% $0.000000 8,092 07 Nov 2024 Common Stock 60 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +1,001 +12% $0.000000 9,092 31 Dec 2024 Common Stock 1,001 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1-for-1
F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4 Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.